AARS1 - alanyl-tRNA synthetase 1 Gene
Also Known as AARS; TTD8; CMT2N; DEE29; HDLS2; EIEE29
Species: Homo sapiens
About AARS1
This gene has 42 transcripts (splice variants), 205 orthologues, 2 paralogues and is associated with 7 phenotypes. Ubiquitous expression in brain (RPKM 59.4), thyroid (RPKM 56.4) and 25 other tissues.
Summary
The human alanyl-tRNA synthetase (AARS) belongs to a family of tRNA synthases, of the class II Enzymes. Class II tRNA synthases evolved early in evolution and are highly conserved. This is reflected by the fact that 498 of the 968-residue polypeptide human AARS shares 41% identity witht the E.coli protein. tRNA synthases are the Enzymes that interpret the RNA code and attach specific aminoacids to the tRNAs that contain the cognate trinucleotide anticodons. They consist of a catalytic domain which interacts with the amino acid acceptor-T psi C helix of the tRNA, and a second domain which interacts with the rest of the tRNA structure. [provided by RefSeq, Jul 2008]
AARS1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001605.3 | NP_001596.2 | alanine--tRNA ligase, cytoplasmic |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables alanine-tRNA ligase activity |
IDA
IDA: Inferred from direct assay
|
27622773 | GOA |
| enables aminoacyl-tRNA editing activity |
IDA
IDA: Inferred from direct assay
|
28493438 | GOA |
| enables peptide lactyltransferase (ATP-dependent) activity |
IDA
IDA: Inferred from direct assay
|
38512451 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in alanyl-tRNA aminoacylation |
IDA
IDA: Inferred from direct assay
|
27622773 | GOA |
| involved in alanyl-tRNA aminoacylation |
IMP
IMP: Inferred from mutant phenotype
|
33909043 | GOA |
| involved in negative regulation of signal transduction by p53 class mediator |
IDA
IDA: Inferred from direct assay
|
38653238 | GOA |
| involved in positive regulation of hippo signaling |
IDA
IDA: Inferred from direct assay
|
38512451 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| is active in cytoplasm |
IDA
IDA: Inferred from direct assay
|
38512451 | GOA |
| is active in nucleus |
IDA
IDA: Inferred from direct assay
|
38512451 | GOA |
AARS1 Protein Structure
tRNA-synt_2c: tRNA synthetases class II (A) (9 - 596)
tRNA_SAD: Threonyl and Alanyl tRNA synthetase second additional domain (694 - 753)
DHHA1: DHHA1 domain (887 - 955)
- 0
- 200
- 400
- 600
- 800
- 968 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
alanine--tRNA ligase, cytoplasmic |
|
Recombinant AARS1 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P75517 | Alanyl-tRNA synthetase Protein, Human (sf9, His) | P49588 (M1-N968) | ≥ 90%, as determined by reducing SDS-PAGE. |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Charcot-Marie-Tooth Disease, Axonal, Type 2n |
|
|
| Developmental And Epileptic Encephalopathy 29 |
|
|
| Leukoencephalopathy, Hereditary Diffuse, With Spheroids 2 |
|
|
| Trichothiodystrophy 8, Nonphotosensitive |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2e |
|
|
| Non-Specific Early-Onset Epileptic Encephalopathy |
|
|
| Charcot-Marie-Tooth Disease |
|
|
| Myositis |
|
|
| Leukoencephalopathy, Hereditary Diffuse, With Spheroids 1 |
|
|
| Peripheral Nervous System Disease |
|
|
| Trichothiodystrophy |
|
|
| Polymyositis |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2d |
|
|
| Charcot-Marie-Tooth Disease, Recessive Intermediate B |
|
|
| Neuronopathy, Distal Hereditary Motor, Type Va |
|
|
| Dermatomyositis |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2u |
|
|
| Charcot-Marie-Tooth Disease, Dominant Intermediate C |
|
|
| Tooth Disease |
|
|
| Charcot-Marie-Tooth Disease Intermediate Type |
|
|
| Usher Syndrome, Type Iiib |
|
|
| Motor Peripheral Neuropathy |
|
|
| Charcot-Marie-Tooth Disease And Deafness |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2a1 |
|
|
| Cholestasis, Intrahepatic, Of Pregnancy, 1 |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2i |
|
|
| Combined Oxidative Phosphorylation Deficiency 12 |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2w |
|
|
| Autosomal Dominant Distal Hereditary Motor Neuronopathy |
|
|
| Antisynthetase Syndrome |
|
|
| Pontocerebellar Hypoplasia, Type 6 |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2l |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2b2 |
|
|
| Cerebral Arteriopathy, Autosomal Dominant, With Subcortical Infarcts And Leukoencephalopathy, Type 2 |
|
|
| Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2f |
|
|
| Microcephaly |
|
|
| Charcot-Marie-Tooth Disease Type 2a2b |
|
|
| Clubfoot |
|
|
| Charcot-Marie-Tooth Disease, X-Linked Dominant, 1 |
|
|
| Developmental And Epileptic Encephalopathy |
|
|
| Perrault Syndrome |
|
|
| Neuromuscular Disease |
|
|
| Mitochondrial Dna Depletion Syndrome 4a |
|
|
| Pontocerebellar Hypoplasia |
|
|
| Hypomyelinating Leukodystrophy |
|
|
| Early Infantile Epileptic Encephalopathy |
|
|
| Congenital Nervous System Abnormality |
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Bos taurus | AARS1 | VGNC | VGNC:25448 |
| Canis familiaris | AARS1 | VGNC | VGNC:37415 |
| Felis catus | AARS1 | VGNC | VGNC:59454 |
| Macaca mulatta | AARS1 | VGNC | VGNC:69482 |
| Rattus norvegicus | AARS1 | RGD | RGD:1304832 |
| Mus musculus | AARS1 | MGD | MGI:2384560 |
| Others | AARS1 | NCBI |